Objective: To determine the predictive value of sentinel node biopsy (SNB)-assisted neck dissection in patients with oral squamous cell carcinoma (SCC) stage T1 to 2N0M0 and to determine the incidence of subclinical metastases.
INTRODUCTION
Oral squamous cell carcinoma (SCC) is predominantly a locoregional disease with a propensity for metastasizing to the cervical lymph nodes. The presence of cervical metastasis is the single most important prognostic factor for survival. Determining the presence or absence of nodal metastasis is of importance for staging, treatment planning, and prognosis.
Despite technical improvements, imaging techniques such as ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) have not proven reliable in determining the presence of lymph node metastasis. In Denmark, patients with oral SCC are treated according to national guidelines. 1 The treatment for early oral SCC stage I and II (T1-2N0M0) is surgical excision of the primary tumor, and a selective neck dissection for levels I to III and for anterior tongue level IV is included, thus with dissection of levels with a risk of having subclinical metastasis in over 10%. Because a patient with a clinically N0 neck might have up to a 30% risk of harboring subclinical (occult) metastasis in the neck, this current treatment policy might lead to an over-treatment of up to 70% of the patients with a selective neck dissection.
The sentinel node (SN), being the initial lymph node to which the primary tumor drains, is believed to be invaded early by metastasis. Identification of the SN by means of an isotope and surgical removal followed by histopathologic examination using a step-serial sectioning method verifies the involvement of the regional lymph nodes. Sentinel node biopsy (SNB) has been validated and reported extensively in breast cancer and cutaneous malignant melanoma, and the procedure is routinely used in the treatment of these malignancies. Even though several studies have reported a high sensitivity rate in using SNB, it still remains unclear whether SNB could replace the use of selective neck dissection in the treatment of the clinically N0 neck in oral SSC (thus improving survival and reducing morbidity).
In oral cancer, the methods used for the histopathologic examination of SNs vary considerably. The use of step-serial sectioning and immunohistochemistry has been shown to increase the detection of subclinical metastases, including the detection of micrometastases. 2 The current recommendation is step-sectioning of the entire lymph node at intervals of 150 m. 3 The aims of this study are 1) to determine the predictive value of SNB-assisted neck dissection in patients with oral SCC stage T1 to 2N0M0 and 2) to determine the incidence of subclinical metastases among a consecutive cohort of patients.
MATERIALS AND METHODS

Patient Eligibility
During the period from October 2003 to January 2007, patients were enrolled into the study. The first five patients were part of a pilot study to achieve a standard set-up for the procedure. From September 2004, the patients were consecutively enrolled when referred according to a catchment area, which covered 1.8 million inhabitants. Pretreatment assessment involved physical examination, endoscopic evaluation of the upper airways, CT or MRI, and radiography of the chest. Inclusion criteria were all patients with invasive oral SCC stage I to II (T1-2N0M0), no previous treatment of the primary tumor or the regional lymph nodes, no previous tumor or neck pathology, and resectable primary tumor.
Sentinel Node Biopsy Procedure
The SNB procedure for the first 32 patients was conducted as previously described. 4 Preoperative lymphoscintigraphy was performed for the majority of patients the day before surgery. Four injections of 110 to 120 MBq (60 -50 MBq for the same day procedure)
99m Tc-labeled human serum albumin ( 99m Tc-Nanocoll; Amersham Health, Little Chalfont, UK) were given to surround the tumor. Dynamic and static lymphoscintigraphic images in lateral and anterior projection were obtained immediately followed by a single photon emission computed tomography (SPECT) low-dose CT. After acquisition of lymphoscintigraphic images, the localization of SNs was determined by consensus reading and denoted as first, second, or third echelon nodes according to their appearance. At time of surgery, the primary tumor was resected before proceeding to SNB to avoid interfering radioactivity from the injection. Blue dye was not used. The localization of the SN was marked on the skin using a hand-held gamma probe (Neo2000; Neoprobe Corporation, Dublin, OH) before the incision was made for selective neck dissection. All radioactive SNs were excised under the guidance of the hand-held gamma probe, radioactivity was measured ex vivo, and the neck level location was noted. A subsequent neck dissection was made after removal of all radioactive lymph nodes. In case of a welllateralized tumor with a contralateral SN, this lymph node only was removed without a subsequent neck dissection on this side of the neck. In the case of a midline tumor, a subsequent bilateral neck dissection was performed after harvesting the SNs.
Histopathologic Examination
The histopathologic examination of the SN was performed in two stages. Initially, the SNs were cut according to the Canniesburn protocol. 5 Subsequently, the SNs were cut according to the Sentinel European Node Trial (SENT). 3 
Canniesburn Protocol
The SNs were fixed in 10% neutral buffered formalin and paraffin embedded. Each SN was bisected through the hilum, when identifiable, or through the long axis of the node. If the thickness of the halves was more than approximately 2 mm, the slices were further sectioned to provide additional 2-mm thick blocks. One hematoxylin-eosin (H&E) stained section was prepared from each block and examined. If no metastases were found, the SNs were processed by step-serial sectioning at six levels at 150-m intervals. Two sections from each level were stained with H&E and cytokeratin antibody AE1/AE3 (DAKO, Glostrup, Denmark), and, in addition, two unstained sections per level were cut. Cytokeratin positivity was compared with the adjacent H&E section to confirm that it represented tumor cells.
Sentinel European Node Trial Protocol
The remaining part of the SNs was cut up and stained as described above. The results of histopathologic examination of the SNs and non-SNs were compared. The examination of the latter used a routine H&E staining. The metastases were classified according to TNM classification into macro-and micrometastases as well as isolated tumor cells (ITC). 6 
Primary Tumor
All tumors were histopathologically graded and categorized by thickness and depth. Tumor thickness was measured from the surface to the point of maximum invasion, and tumor depth was measured from a line drawn across the adjacent mucosal surface to the point of maximum invasion.
Statistical analysis was carried out using SPSS, version 13, for Windows (SPSS Inc., Chicago, IL). Descriptive statistics are given as median, percentage, and range. Associations between histologic parameters and the presence of metastases were made using Fisher's exact test or the 2 test. A P value less than .05 was considered significant. The study was conducted according to the Helsinki Declaration II and was approved by the local ethics committees.
RESULTS
Sixty-seven consecutive patients with oral SCC T1 to 2N0M0 were recruited for the study. Fifty-tree patients were found eligible for SNB-assisted neck dissection, and, in total, 51 SNB-assisted neck dissection procedures were performed ( Fig. 1) .
In 36 (71%) of the 51 patients, the clinical TNM classification was based on physical examination, endoscopy assessment of the upper airways, and chest radiograph. In addition, 18% (9 of 51) of the patients received a CT scan, 10% (5 of 51) had a MRI scan, and 2% (1 of 51) had an ultrasound examination performed to evaluate the nodal status of the neck.
Twenty-tree patients were women, and 28 were men, with a median age of 58 (range, 29 -90) years. The median follow-up period for all patients was 14 (range, 1-39) months. One patient with positive SNs was treated for a local recurrence 1 year and 10 months after surgery with postoperative radiotherapy (case 3) (Table I) . Four patients died, one from the primary tumor, two from other cancers not related to the head and neck, and one from unrelated causes.
Primary Tumor
Twenty-three patients were preoperatively clinically classified as T1, and 28 were classified as T2. The sites of the primary tumor were as follows: anterior two thirds of the tongue (51%), floor of mouth (41%), retromolar trigone (6%), and buccal mucosa (2%). Twentyfour (47%) tumors were histologically classified as well differentiated, 22 (43%) as moderately differentiated, and 4 (8%) as poorly differentiated. One (2%) tumor was classified as a microinvasive SCC. The median tumor thickness was 3.5 (range, 1-15) mm, and the median tumor depth was 3.5 (range, 0 -15) mm.
Sentinel Nodes
SNs were harvested from all the neck levels identified on SPECT-CT in 90% (46 of 51) of the patients. In five patients, the SN in one level could not be identified during surgery. All five patients underwent lymphoscintigraphy the day before surgery, with an unintended time interval of more than 24 hours at time of surgery.
A total of 181 SNs were excised, with a median of 3 (range, 1-7) SNs per patient. Of the 51 patients undergoing SNB-assisted neck dissection, 14 patients had SNs identified bilaterally, of whom 3 had bilateral neck dissection because the primary tumor was located in the midline. All other tumors were localized laterally. 
Histopathological Examination of Sentinel Nodes
The incidence of subclinical metastases was 22% (11 of 51). No metastases were identified in the non-SNs, excluding one case mentioned below. Routine H&E evaluation pathologically upstaged 18% (2 of 11). H&E and step-serial sectioning upstaged 18% (2 of 11). Cytokeratin AE1/AE3 and step-serial sectioning upstaged 64% (7 of 11). Thus, 4% (2 of 51) of the patients were upstaged by routine H&E, whereas 18% (9 of 49) of the patients were upstaged by additional histopathology (Fig. 2) .
Nine (16%) of the 51 patients were evaluated as positive as a result of stage one of the histopathologic examination showing either macro-or a micrometastases or ITC (Figs. 3 and 4) . One patient with a tongue tumor had one of five SNs containing only ITC that was located at level IV and a non-SN in level IIA containing a macrometastasis (case 8) (Table I) .
Three (6%) of the 51 patients were additionally scored positive when the entire SN was cut up; ITC were identified in two patients with no initial subclinical metastasis (case 1 and 9) ( Table I ). In addition, ITC was identified in one SN in a patient whose other SNs contained macro-and micrometastases (case 3) (Table I) .
Association between Histologic Parameters and Presence of Metastases
Tumor depth and thickness were statistically significantly associated with cervical lymph node metastases (P ϭ .028; odds ratio, 5.639). In the group in which the depth or thickness of the primary tumor exceeded 4 mm, the incidence of metastasis was 58% (7 of 19). In contrast, the incidence of metastasis was 9% (3 of 32) when the depth or thickness of the primary tumor was equal to or less than 4 mm. Cervical lymph node metastases were not associated with tumor classification, localization of the primary tumor, or histopathologic grading.
DISCUSSION
The International Union Against Cancer has established a certainty factor reflecting the validity of classification according to the diagnostic methods used. Five grades are defined (C1-C5). Grade C1 is lowest grade related to evidence obtained using standard diagnostic methods (e.g., physical examination, conventional radiography) and C5 the highest grade with evidence obtained postmortem.
The TNM classification of the 51 patients included in this study was for the majority of the patients (71%) based on physical examination, endoscopic assessment of the upper airways, and chest radiograph, corresponding to certainty factor grade C1. It is well known that time delay has an adverse influence on prognosis, especially in patients with oral cancer. Because the access to CT and especially MRI in Denmark is limited (i.e., associated with a minimum waiting time of more than 2 wk), we elected to proceed with the treatment rather than wait for a scan even though the classificatory certainty of this affirmation is higher. The lack of CT or MRI may also explain why 10 of 67 patients accrued at time of operation were upgraded to a higher stage and had to be excluded from the study (Fig. 1) .
The incidence of subclinical metastases in our study of patients with oral SCC T1 to 2 and a clinically N0 neck was 22% (11 of 51). All of the metastases were located ipsilaterally in levels I to III, with the exception of one case in which an ITC (SN) was located in level IV and a macrometastasis was located in level IIA (non-SN). For tongue tumors, the metastases were located at level II and III, with lymphatic drainage primarily to these levels. For floor of mouth tumors, the localization of metastases was located at level II, with lymphatic drainage to level I and II. These findings are in accordance with the findings made by Shah et al. 7 The lymphatic drainage pattern and SNs were named consecutively SN1, SN2, etc. after excision. SN ϭ sentinel node; SND ϭ selective neck dissection; facial ϭ facial lymph node; sin ϭ sinister (left); ITC ϭ isolated tumor cells; mi ϭ micrometastasis; ma ϭ macrometastasis; Ϫ ϭ negative.
therefore the localization of SNs were, however, in some of our cases unexpected (i.e., 11 well-lateralized tumors had a bilateral drainage pattern, and a significant number of SNs were found in level IV). These lymph nodes were not harvested by the recommended selective neck dissection. 1 None of the identified contralateral SNs contained metastases. However, contralateral metastases have been found in other SNB studies. 8, 9 This individual lymphatic mapping is the main advantage of using SNB in substitution for selective neck dissection.
SNB might be regarded as a minimally invasive procedure with the opportunity of reducing morbidity for patients with a negative SNB. Such avoidance of selective neck dissection should result in maintenance of normal lubrication of the oral cavity. In contrast, neck dissection, comprising the subsequent removal of the submandibular gland, might lead to complaints of varying degrees of xerostomia. Patients treated for a midline tumor and having both submandibular glands resected are especially prone to these symptoms. However, with implementation of SNB only, many patients having a positive SNB will have to undergo a second procedure, corresponding to 22% in our study. Future studies will determine whether implementation of SNB alone reduces patient morbidity. Nine patients would have been upstaged according to the Canniesburn protocol, which includes examination of the central part of the lymph node. Cutting up the entire SN identified three patients with ITC. According to the TNM classification, the finding of the additional ITC does not lead to an upgrading of the nodal classification. 6 A central aspect of SNB research will be to assess the prognostic significance of ITC. Currently, the incidence of metastasis in non-SN has not been studied in oral SCC with ITC only in the SNs. In other words, does the finding of ITC justify a subsequent selective neck dissection in a patient with T1 to 2 oral SCC? To answer this question appropriately, the non-SNs harvested in this study should be examined using step-serial sectioning and immunohistochemistry. The impact of ITC in an SN can only be determined by performing a subsequent selective neck dissection, as illustrated by one of our cases (case 8) (Table  I) in which an SN contained ITC and a non-SN contained a macrometastasis. Because half of the non-SN was infiltrated by tumor cells, this might have caused the obstruction of the lymphatic flow, making the radioactive colloid bypass the lymph node and be caught in the other lymph nodes downstream. It is worth noting that the CT scan in this case showed no evidence of lymph node involvement.
In our opinion, the finding of ITC in SNs should necessitate a subsequent selective neck dissection to pathologically stage the neck, but additional therapeutic procedures (e.g., adjuvant radiotherapy) are not advocated. In breast cancer, micrometastases appear to have a small but significantly adverse effect on survival. 10 Therefore, it appears to be of importance to determine the presence of micrometastases in head and neck cancer as well. 2 In accordance with the national guidelines, the finding of micrometastases should have therapeutic consequences. Thus, postoperative radiotherapy is indicated in any patient upstaged to N2 or higher. Consequently, in our series, postoperative radiotherapy was performed in the patient staged pN2b(mi)(SN) (case 8) ( Table I) .
The treatment of a patient with oral SCC using SNB is a two-stage procedure. 11 The first stage involves the identification of the SN and excision of the lymph node followed by thorough histopathologic examination using step-serial sectioning and immunohistochemistry to identify possible metastasis. The second stage involves the planning of a possible subsequent neck dissection depending on the histopathologic result. To reduce the time delay between the first stage and the second stage, the value of frozen-section analysis has been addressed by several authors with variable results. 12, 13 In 7 of our 11 positive cases, the metastases were located within the first millimeter of the 2 mm block and would only have been identified using step-serial sectioning and immunohistochemistry. Three ITC were identified in the last millimeter of the 2 mm block. Because frozen section analysis uses some of the lymphatic tissue and leaves less tissue for conventional histopathologic analysis, it is possible that these metastases would have been missed using frozen sections, leading to a false-negative result. Six of 11 patients had micrometastases being less than or equal to 2 mm. The current recommendation in SNB in oral cancer is therefore to use step-sectioning of the entire node at intervals of 150 m. 3 Because the impact of micrometastasis and ITC still remains unclear in head and neck SCC, it is imperative to follow the recommendations and to report the findings uniformly, as requested by SENT. This will help to evaluate the prognostic significance of SNB.
Difficulties encountered with the SNB procedure involve well-known phenomena such as shine-through from the injection site or scattering. 11 These are most prevalent in the submandibular and submental triangles of the neck. In two of the five patients in whom the SN at one level could not be identified, the nodes were in close proximity to the injection site. The time interval between the injection of radioactive colloid and the time of surgery has also been shown to be of importance. 4 What was in common for all five patients in our study in whom the SN in one level could not be identified was a low radioactivity caused by a time delay before surgery. For all patients except one, the radioactivity was less than the aim to achieve at least 10 MBq at the time of surgery. To avoid this problem and to ensure appropriate radioactivity at time of surgery, a same-day procedure is recommended. With the exclusion of these five patients, the sensitivity of SNB in our study was 100%. This sensitivity rate is similar to other studies. 14 The incidence of subclinical metastases in this study is low in comparison with other studies, with an incidence ranging from 25% to 44%. [15] [16] [17] [18] Most of these studies, however, included oropharyngeal tumors and were not consecutive cohort studies representing a well-defined region, therefore making comparison difficult. Several studies have shown that tumor thickness is associated with lymph node metastasis (i.e., the risk of lymph node metastasis is higher with increasing tumor thickness/depth). 19 The median tumor depth and thickness for the primary tumor in our study was 3.5 mm, which may explain the low incidence of subclinical metastases. With 4 mm as a cutoff measure, the incidence of metastasis was 58% (7 of 19) for the group with tumor depths greater than 4 mm as opposed to the group with a depth of 4 mm or less, in which the incidence of metastases was 9% (3 of 32), representing a statistically significant difference.
CONCLUSION
This study on SNB-assisted neck dissection proved to be technically feasible and capable of identifying subclinical (occult) metastasis, thus accurately staging the neck with a high degree of sensitivity in patients with oral SCC T1 to 2N0M0, when using additional histopathology techniques. In patients with a tumor invasion of 4 mm and less, the risk of having metastases was 9%. The majority of patients in this study would have been spared selective neck dissection had reliance on SNB been used and selective neck dissection performed only in the case of a positive SN. Further studies are needed to determine whether the implementation of SNB alone in the treatment of oral SCC will reduce patient morbidity and be as equally effective as selective neck dissection.
